Brian M. Lingerfelt, MD
Medical Oncology and Hematology Specialist
Brian M. Lingerfelt, MD earned his undergraduate degree in Chemistry from Furman University in Greenville, South Carolina. He graduated from Virginia Commonwealth University School of Medicine at the Medical College of Virginia Campus in Richmond, Virginia, and continued his medical training with an internship and residency in Internal Medicine at Virginia Commonwealth University Health System. He completed his fellowship in Hematology and Medical Oncology at the Emory University Winship Cancer Institute in Atlanta, Georgia.
Dr. Lingerfelt performed extensive laboratory research at Furman University synthesizing anti-cancer drugs and at Virginia Commonwealth University Health System analyzing the effect of checkpoint kinase inhibitors in multiple myeloma cell lines. His clinical research at Emory University focused on the inflammatory response to tyrosine kinase inhibitors in kidney cancer.
He has published in the Journal of Supportive Oncology, the Journal of Pharmaceutical and Biomedical Analysis, and Bioorganic and Medicinal Chemistry. He is a member of the American Medical Association, the American Society of Clinical Oncology, and the American Society of Hematology. Dr. Lingerfelt joined Charleston Oncology, P.A., in 2012.
Choose your preferred location
West Ashley
North Charleston
Downtown
Summerville
Mt. Pleasant
Walterboro
Send UsA Message
Early-Stage Breast Cancer Characteristics and Treatment Options
Early-Stage Breast Cancer Characteristics and Treatment OptionsA rise in early-stage breast cancer diagnosis may result from better screening technology and a raised awareness of the importance of annual mammograms. An early-stage breast cancer diagnosis is contained...
Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World
Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”
Lowcountry doctors, patients helped secure ‘game-changer’ cancer treatment approval
Clinical trials for a newly-approved cancer treatment for lung cancer in the Lowcountry helped get the drug ready for people around the world, Lowcountry medical officials say.
Lowcountry Breast Cancer Survivors On Finding The Right Oncology Practice
How should one go about finding the right oncology practice? We interviewed ten Lowcountry breast cancer patients to get their perspectives and advice.
Sarcoma and Bone Cancer Awareness
July is Sarcoma and Bone Cancer Awareness Month. Sarcomas are a rare group of cancers in which malignant cells form in the bones or soft tissues of the body.
May is Skin Cancer Awareness Month
Melanoma is a type of skin cancer that develops when melanocytes start to grow out of control. Watch a video to learn more about melanoma from Dr. Charles S. Holladay.
